The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Behavioural and biochemical evidence for interactions between Δ9‐tetrahydrocannabinol and nicotine
Open accessAbstract
Behavioural and pharmacological effects of Δ9‐tetrahydrocannabinol (THC) and nicotine are well known. However, the possible interactions between these two drugs of abuse remain unclear in spite of the current association of cannabis and tobacco in humans. The present study was designed to analyse the consequences of nicotine administration on THC‐induced acute behavioural and biochemical responses, tolerance and physical dependence. Nicotine strongly facilitated hypothermia, antinociception and hypolocomotion induced by the acute administration of THC. Furthermore, the co‐administration of sub‐threshold doses of THC and nicotine produced an anxiolytic‐like response in the light–dark box and in the open‐field test as well as a significant conditioned place preference. Animals co‐treated with nicotine and THC displayed an attenuation in THC tolerance and an enhancement in the somatic expression of cannabinoid antagonist‐precipitated THC withdrawal. THC and nicotine administration induced c‐Fos expression in several brain structures. Co‐administration of both compounds enhanced c‐Fos expression in the shell of the nucleus accumbens, central and basolateral nucleus of the amygdala, dorso‐lateral bed nucleus of the stria terminalis, cingular and piriform cortex, and paraventricular nucleus of the hypothalamus. These results clearly demonstrate the existence of a functional interaction between THC and nicotine. The facilitation of THC‐induced acute pharmacological and biochemical responses, tolerance and physical dependence by nicotine could play an important role in the development of addictive processes. British Journal of Pharmacology (2002) 135, 564–578; doi:10.1038/sj.bjp.0704479
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Imperato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,614
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321
SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system
Tsou, K., Brown, S., Sañudo-Peña, M. C., Mackie, K., & Walker, J. M. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00436-3 · Cited by 1,586
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Addiction, Dopamine, and the Molecular Mechanisms of Memory
Berke, J. D., & Hyman, S. E. (2000) · Neuron · doi:10.1016/s0896-6273(00)81056-9 · Cited by 1,181
Tanda, G., Pontieri, F. E., & Chiara, G. D. (1997) · Science · doi:10.1126/science.276.5321.2048 · Cited by 1,080
Wise, R. A. (1996) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(96)80079-1 · Cited by 1,072
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M., & Bonner, T. I. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5780 · Cited by 1,064
Koob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
The effects of cannabinoids on the brain
Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 812
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769
Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses
Filliol, D., Ghozland, S., Chluba, J., Martin, M., Matthes, H. W. D., Simonin, F., Befort, K., Gavériaux-Ruff, C., Dierich, A., LeMeur, M., et al. (2000) · Nature Genetics · doi:10.1038/76061 · Cited by 672
Self-citationMolecular and cellular aspects of nicotine abuse
Dani, J. A., & Heinemann, S. (1996) · Neuron · doi:10.1016/s0896-6273(00)80112-9 · Cited by 605
Cannabis: pharmacology and toxicology in animals and humans
ADAMS, I. B., & MARTIN, B. R. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911115852.x · Cited by 570
Involvement of the Extracellular Signal-Regulated Kinase Cascade for Cocaine-Rewarding Properties
Valjent, E., Corvol, J.-C., Pagès, C., Besson, M.-J., Maldonado, R., & Caboche, J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08701.2000 · Cited by 549
Self-citationReduced antinociception in mice lacking neuronal nicotinic receptor subunits
Marubio, L. M., Arroyo-Jimenez, M. D. M., Cordero-Erausquin, M., Léna, C., Novère, N. L., d'Exaerde, A. D. K., Huchet, M., Damaj, M. I., & Changeux, J.-P. (1999) · Nature · doi:10.1038/19756 · Cited by 542
Activation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499 · cited 2×
“Cannabinoid agonists (Mailleux et al., 1994; Rodriguez de Fonseca et al., 1997; McGregor et al., 1998) and nicotine (Ren & Sagar, 1992; Salminen et al., 1996; Mathieu-Kia et al., 1998) have been reported to induce c-Fos expression in various brain areas.”
BackgroundHollister, L. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 497
Orr-Urtreger, A., Göldner, F. M., Saeki, M., Lorenzo, I., Goldberg, L., De Biasi, M., Dani, J. A., Patrick, J. W., & Beaudet, A. L. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-23-09165.1997 · Cited by 497
Acetylcholine-mediated modulation of striatal function
Calabresi, P., Centonze, D., Gubellini, P., Pisani, A., & Bernardi, G. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01501-5 · Cited by 440
Absence of opiate rewarding effects in mice lacking dopamine D2 receptors
Maldonado, R., Saiardi, A., Valverde, O., Samad, T. A., Roques, B. P., & Borrelli, E. (1997) · Nature · doi:10.1038/41567 · Cited by 434
Self-citationSimonin, F., Valverde, O., Smadja, C., Slowe, S., Kitchen, I., Dierich, A., Le Meur, M., Roques, B. P., Maldonado, R., & Kieffer, B. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.4.886 · Cited by 418
Self-citationCannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra
French, E. D., Dillon, K., & Wu, X. (1997) · NeuroReport · doi:10.1097/00001756-199702100-00014 · Cited by 374
Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors
Gessa, G., Melis, M., Muntoni, A., & Diana, M. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01442-8 · Cited by 370
The paradox of nicotinic acetylcholine receptor upregulation by nicotine
Wonnacott, S. (1990) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(90)90242-z · Cited by 357
Pharmacological characterization of cannabinoids in the elevated plus maze.
Onaivi, E. S., Green, M. R., & Martin, B. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13195-9 · Cited by 311
Nicotinic receptor function: new perspectives from knockout mice
Cordero-Erausquin, M., Marubio, L. M., Klink, R., & Changeux, J.-P. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01489-9 · Cited by 295
Xu, W., Gelber, S., Orr-Urtreger, A., Armstrong, D., Lewis, R. A., Ou, C.-N., Patrick, J., Role, L., De Biasi, M., & Beaudet, A. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5746 · Cited by 290
Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording
Calabresi, P., Lacey, M. G., & North, R. A. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb16873.x · Cited by 285
Xu, W., Orr-Urtreger, A., Nigro, F., Gelber, S., Sutcliffe, C. B., Armstrong, D., Patrick, J. W., Role, L. W., Beaudet, A. L., & De Biasi, M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09298.1999 · Cited by 285
Martin, M., Ledent, C., Parmentier, M., Maldonado, R., & Valverde, O. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00287.x · Cited by 237
Self-citationLepore, M., Vorel, S. R., Lowinson, J., & Gardner, E. L. (1995) · Life Sciences · doi:10.1016/0024-3205(95)00191-8 · Cited by 237
Spinal and supraspinal components of cannabinoid-induced antinociception.
Lichtman, A. H., & Martin, B. R. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20242-7 · Cited by 217
Watkins, S. S., Stinus, L., Koob, G. F., & Markou, A. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35389-3 · Cited by 214 · cited 3×
“…et al., 1998; Ledent et al., 1999; Lichtman et al., 2001) and nicotine (Costall et al., 1989; Rissinger & Oakes, 1995; Hildebrand et al., 1999; Watkins et al., 2000) required to induce these anxiolytic and rewarding e ects are much lower than those needed to develop tolerance and dependence.”
BackgroundA behavioural model to reveal place preference to Δ9-tetrahydrocannabinol in mice
Valjent, E., & Maldonado, R. (2000) · Psychopharmacology · doi:10.1007/s002130050013 · Cited by 214
Self-citationNestler, E. J. (2000) · Nature Genetics · doi:10.1038/81570 · Cited by 206
Gifford, A. N., & Ashby, C. R. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13092-9 · Cited by 199
Hutcheson, D. M., Tzavara, E. T., Smadja, C., Valjent, E., Roques, B. P., Hanoune, J., & Maldonado, R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702228 · Cited by 192
Self-citationThe actions of nicotine and cocaine in a mouse model of anxiety
Costall, B., Elizabeth Kelly, M., Naylor, R. J., & Onaivi, E. S. (1989) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(89)90450-4 · Cited by 186
Serum and glucocorticoid‐regulated protein kinases: Variations on a theme
Tessier, M., & Woodgett, J. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20894 · Cited by 177
De Fonseca, F. R., Gorriti, M. A., Fernández-Ruiz, J. J., Palomo, T., & Ramos, J. A. (1994) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)90108-2 · Cited by 175
Rodríguez de Fonseca, F., Rubio, P., Menzaghi, F., Merlo-Pich, E., Rivier, J., Koob, G. F., & Navarro, M. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12276-3 · Cited by 175
Valverde, O., Noble, F., Beslot, F., Daugé, V., Fournié‐Zaluski, M., & Roques, B. P. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01558.x · Cited by 173
Lichtman, A. H., Sheikh, S. M., Loh, H. H., & Martin, B. R. (2001) · PubMed · Cited by 156
Nicotine receptors in the mammalian brain
Luetje, C. W., Patrick, J., & Séguéla, P. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.10.2197155 · Cited by 145
Nicotine-induced conditioned place preference and conditioned place aversion in mice
Risinger, F. O., & Oakes, R. A. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)00007-j · Cited by 142
Gessa, G. L., Casu, M. A., Carta, G., & Mascia, M. S. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00486-5 · Cited by 142
Hollister, L. E. (1986) · PubMed · Cited by 130
CB1 receptor antagonist precipitates withdrawal in mice exposed to Delta9-tetrahydrocannabinol.
Cook, S. A., Lowe, J. A., III, & Martin, B. R. (1998) · PubMed · Cited by 126
Cannabinoid Withdrawal Syndrome Is Reduced in Pre-Proenkephalin Knock-Out Mice
Valverde, O., Maldonado, R. J., Valjent, E., Zimmer, A. M., & Zimmer, A. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09284.2000 · Cited by 111
Self-citationWewers, M. E., Dhatt, R. K., Snively, T. A., & Tejwani, G. A. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01095-1 · Cited by 111
Hildebrand, B. E., Panagis, G., Svensson, T. H., & Nomikos, G. G. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00055-x · Cited by 110
Mathieu-Kia, A.-M., & Besson, M. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00338-0 · Cited by 108
Self-citationMallet, P. E., & Beninger, R. J. (1998) · Life Sciences · doi:10.1016/s0024-3205(98)00226-4 · Cited by 105
Malone, D. T., & TAYLOR, D. A. H. B. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702753 · Cited by 99
Sekine‐Aizawa, Y., Hama, E., Watanabe, K., Tsubuki, S., Kanai‐Azuma, M., Kanai, Y., Arai, H., Aizawa, H., Iwata, N., & Saido, T. C. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01462.x · Cited by 97
Fan, F., Tao, Q., Abood, M. E., & Martin, B. R. (1996) · Brain Research · doi:10.1016/0006-8993(95)01113-7 · Cited by 97
Nava, F. A., Carta, G., Battasi, A. M., & Gessa, G. L. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703413 · Cited by 92
Gifford, A. N., Samiian, L., Gatley, S. J., & Ashby, C. R. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00082-4 · Cited by 83
Acquas, E., Pisanu, A., Marrocu, P., & Chiara, G. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00403-9 · Cited by 83
Dhatt, R. K., Gudehithlu, K. P., Wemlinger, T. A., Tejwani, G. A., Neff, N. H., & Hadjiconstantinou, M. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041878.x · Cited by 80
Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine
Ren, T., & Sagar, S. M. (1992) · Brain Research Bulletin · doi:10.1016/0361-9230(92)90127-j · Cited by 79
Pertwee, R. G., & Ross, T. M. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90044-c · Cited by 78
Gifford, A. N., Bruneus, M., Gatley, S. J., & Volkow, N. D. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703599 · Cited by 77
Nicotine and heroin augment cocaine-induced dopamine overflow in nucleus accumbens
Zernig, G., O'Laughlin, I. A., & Fibiger, H. C. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01184-9 · Cited by 75
Interactions of Δ9-tetrahydrocannabinol with d-Amphetamine, cocaine, and nicotine in rats
Pryor, G. T., Larsen, F. F., Husain, S., & Braude, M. C. (1978) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(78)90320-9 · Cited by 74
Expression of fos protein in various rat brain areas following acute nicotine and diazepam
Salminen, O., Lahtinen, S., & Ahtee, L. (1996) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(95)02132-9 · Cited by 70
Carta, G., Nava, F. A., & GESSA, G. L. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00738-0 · Cited by 67
Pharmacology of some Marijuana Constituents and Two Heterocyclic Analogues
Dewey, W. L., Harris, L. S., Howes, J. F., et al. (1970) · Nature · doi:10.1038/2261265a0 · Cited by 64
A comparison of Δ9-THC and anandamide induced c-fos expression in the rat forebrain
McGregor, I. S., Arnold, J. C., Weber, M. F., Topple, A. N., & Hunt, G. E. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00549-6 · Cited by 59
Acquas, E., Pisanu, A., Marrocu, P., et al. (2000) · UNICA IRIS Institutional Research Information System (University of Cagliari) · Cited by 56
Mathieu-Kia, A.-M., Caboche, J., & Besson, M. (1996) · Synapse · Cited by 27
Self-citationXiao (1998) · doi:10.1002/(sici)1098-2396(199808)29:4
Cited by
Tzschentke, T. M. (2007) · Addiction Biology · doi:10.1111/j.1369-1600.2007.00070.x · Cited by 1,336
Involvement of the endocannabinoid system in drug addiction
Maldonado, R., Valverde, O., & Berrendero, F. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.008 · Cited by 580
Self-citationCANNABINOID RECEPTORS AS THERAPEUTIC TARGETS
Mackie, K. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141254 · Cited by 505
Endocannabinoid system and stress and anxiety responses
VIVEROS, M., MARCO, E., & FILE, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.029 · Cited by 485
Patel, S., Roelke, C. T., Rademacher, D. J., Cullinan, W. E., & Hillard, C. J. (2004) · Endocrinology · doi:10.1210/en.2004-0638 · Cited by 475
Metadata
- Authors
- Valjent, E., Mitchell, J. M., Besson, M., Caboche, J., & Maldonado, R.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2002-01
- Volume
- 135
- Issue
- 2
- Pages
- 564-578
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W1983885464
- Cited by
- 321
- References
- 76
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.